TY - JOUR
T1 - Corrigendum: Investigation of Nrf2, AhR and ATF4 activation in toxicogenomic databases
AU - Zgheib, Elias
AU - Limonciel, Alice
AU - Jiang, Xiaoqi
AU - Wilmes, Anja
AU - Wink, Steven
AU - Van De Water, Bob
AU - Kopp-Schneider, Annette
AU - Bois, Frederic Y.
AU - Jennings, Paul
PY - 2019/6/4
Y1 - 2019/6/4
N2 - In the original article, we neglected to mention that this work was partly supported by the EU-ToxRisk project (An Integrated European "Flagship" Program Driving Mechanism-Based Toxicity Testing and Risk Assessment for the 21st Century) funded by the European Commission under the Horizon 2020 programme (Grant Agreement No. 681002). A correction has therefore been made to the Acknowledgments: "The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking (IMIJU) under grant agreement number 115439, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. This work was supported by the 2015 CEFIC-LRI award (AL) and partly supported by the EU-ToxRisk project (An Integrated European "Flagship" Program Driving Mechanism-Based Toxicity Testing and Risk Assessment for the 21st Century) funded by the European Commission under the Horizon 2020 programme (Grant Agreement No. 681002). This publication reflects only the author's views and neither the IMI JU nor EFPIA nor the European Commission are liable for any use that may be made of the information contained therein." The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
AB - In the original article, we neglected to mention that this work was partly supported by the EU-ToxRisk project (An Integrated European "Flagship" Program Driving Mechanism-Based Toxicity Testing and Risk Assessment for the 21st Century) funded by the European Commission under the Horizon 2020 programme (Grant Agreement No. 681002). A correction has therefore been made to the Acknowledgments: "The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking (IMIJU) under grant agreement number 115439, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. This work was supported by the 2015 CEFIC-LRI award (AL) and partly supported by the EU-ToxRisk project (An Integrated European "Flagship" Program Driving Mechanism-Based Toxicity Testing and Risk Assessment for the 21st Century) funded by the European Commission under the Horizon 2020 programme (Grant Agreement No. 681002). This publication reflects only the author's views and neither the IMI JU nor EFPIA nor the European Commission are liable for any use that may be made of the information contained therein." The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
UR - http://www.scopus.com/inward/record.url?scp=85068961342&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068961342&partnerID=8YFLogxK
U2 - 10.3389/fgene.2019.00517
DO - 10.3389/fgene.2019.00517
M3 - Erratum / Corrigendum
C2 - 31231426
SN - 1664-8021
VL - 10
JO - Frontiers in Genetics
JF - Frontiers in Genetics
IS - JUNE
M1 - 517
ER -